Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|May 11, 2017

Charter Medical, INCELL Announce Distribution Agreement

The partnership provides Charter Medical the exclusive rights to market, sell, and distribute INCELL media products on a global basis.

Charter Medical Ltd., a manufacturer of products for the regenerative medicine and bioprocessing industries announced a partnership with INCELL Corporation that provides Charter Medical the exclusive rights to market, sell, and distribute INCELL media products on a global basis. INCELL develops and manufactures specialty medias and formulated solutions for tissue and cell collection, transport, processing, and storage.

The partnership will enable both organizations to meet the growing customer demand for more comprehensive solutions in cell culture, cell expansion, and cryopreservation, Charter Media reported in a press release. 

Source: Charter Medical


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.